03:57 PM EDT, 03/26/2025 (MT Newswires) -- Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index down 0.6% and the Health Care Select Sector SPDR Fund (XLV) shedding 0.4%.

The iShares Biotechnology ETF (IBB) fell 1.4%.

In corporate news, federal prosecutors are investigating a claim brought by GSK (GSK) that Pfizer ( PFE ) delayed announcing the success of its COVID vaccine in 2020 until after that year's election, The Wall Street Journal reported. GSK shares fell 0.5%, and Pfizer ( PFE ) shed 1.4%.

Novo Nordisk's ( NVO ) settlement on the out-of-pocket price cap of insulin for Minnesota residents at $35 per month for the next five years was approved by a federal court in New Jersey, Bloomberg reported, citing a court document. Novo shares were retreating 2.6%.

OSR (OSRH) shares soared 136% after its Vaximm unit said final data from a phase 2a trial showed its vaccine candidate, VXM01, plus avelumab could "offer meaningful clinical benefit" in people with recurrent glioblastoma, a type of aggressive brain cancer.

Jaguar Health ( JAGX ) shares fell 5% after the company struck deals to sell up to nearly $3.5 million in convertible promissory notes to Chief Executive Officer Lisa Conte, three board members, seven other senior executives and selected investors.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.